CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Preferred Stock	Common Stock	Additional Paid-in Capital	Other Comprehensive Income (Loss)	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment
Balance at Dec. 31, 2019	$ 248,693	$ (25)	$ 0	$ 144	$ 167,677	$ 10,281	$ 70,591	$ (25)
Balance (in shares) at Dec. 31, 2019				14,414,821
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	2,133						2,133
Other comprehensive income (loss)	(4,028)					(4,028)
Dividends declared	(1,302)						(1,302)
Shares issued under share-based compensation plans (in shares)				58,733
Shares issued under share-based compensation plans	0
Repurchases of common stock (in shares)				(523,583)
Repurchases of common stock	(6,750)			$ (5)			(6,745)
Share-based compensation	453				453
Balance (in shares) at Mar. 31, 2020				13,949,971
Balance at Mar. 31, 2020	239,174		0	$ 139	168,130	6,253	64,652
Balance at Dec. 31, 2020	158,160		0	$ 137	169,298	11,386	(22,661)
Balance (in shares) at Dec. 31, 2020				13,717,908
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(19,381)						(19,381)
Other comprehensive income (loss)	(7,200)					(7,200)
Issuance of common stock (in shares)				3,500,000
Issuance of common stock	15,122			$ 35	15,087
Shares issued under share-based compensation plans (in shares)				95,553
Shares issued under share-based compensation plans	1			$ 1
Share-based compensation	407				407
Balance (in shares) at Mar. 31, 2021				17,313,461
Balance at Mar. 31, 2021	$ 147,109		$ 0	$ 173	$ 184,792	$ 4,186	$ (42,042)